Covid-19 vaccine

  • Russian doctors wary of rapidly approved COVID-19 vaccine, survey shows
    MOSCOW, August 14 (Reuters): A majority of Russian doctors would not feel comfortable being injected with Russia's new COVID-19 vaccine due to the lack of sufficient data about it and its super-fast approval, a survey of more than 3,000 medical professionals showed on Friday. Russia has said that the world's first vaccine for the novel coronavirus will be rolled out by the end of this month, with doctors among those set to be administered with it on a voluntary basis.
  • World reaction to Russia's COVID-19 vaccine
    Reuters Russia's granting of regulatory approval to a COVID-19 vaccine after less than two months of human testing has prompted expressions of caution as well as interest from around the world. Moscow said on Wednesday that the first batch of the vaccine would be ready for some medics within two weeks and rejected safety concerns as "groundless". Here is a summary of the reaction: INQUIRIES Israel will examine Russia's COVID-19 vaccine and enter negotia
  • Russia says medics to get anti-COVID shots in two weeks, rejects safety concerns
    MOSCOW, August 12 (Reuters): Russia said on Wednesday the first batch of its Covid-19 vaccine would be ready for some medics within two weeks and rejected as "groundless" safety concerns aired by some experts over Moscow's rapid approval of the drug. President Vladimir Putin said on Tuesday that Russia had become the first country to grant regulatory approval to a COVID-19 vaccine, after less than two months of human testing. The vaccine has not yet completed i
  • Russia names new COVID-19 vaccine 'Sputnik V' in reference to Cold War space race
    MOSCOW, August 11 (Reuters): Russia has named its first approved COVID-19 vaccine 'Sputnik V' for foreign markets, a reference to the world's first satellite and what Moscow sees as its success at becoming the first country to approve a vaccine, a top official said on Tuesday. Kirill Dmitriev, head of the country's RDIF sovereign wealth fund, said Russia had already received requests from more than 20 countries for 1 billion doses of its newly-registered COVID-1
  • Russia bats for safety of its Covid-19 vaccine
    Moscow, August 4 (IANS) The Russian Ministry of Defence has said that a Covid-19 vaccine that it developed in partnership with the Gamaleya Scientific Research Institute of Epidemiology and Microbiology appears to be safe. On August 3, a "final medical examination" of participants in clinical trials of the vaccine took place at the Burdenko Main Military Clinical Hospital, it said in a statement. The results clearly showed that all volunteers had a clear immune response
  • Russian COVID-19 vaccine approval imminent, source says
    MOSCOW, July 29 (Reuters): Russia's first potential COVID-19 vaccine will win local regulatory approval in the first half of August and be administered to frontline health workers soon afterwards, a development source close to the matter told Reuters. A state research facility in Moscow - the Gamaleya Institute - completed early human trials of the adenovirus-based vaccine this month and expects to begin large-scale trials in August. The vaccine will win regulatory appro
  • Covid vax likely to work with multiple doses: Bill Gates
    San Francisco, July 23 (IANS) People might have to take multiple doses of a potential Covid-19 vaccine to protect themselves from the disease, said Microsoft Co-founder Bill Gates. The billionaire philanthropist told CBS News on Wednesday that "none of the vaccines at this point appear like they'll work with a single dose." Over 150 Covid-19 vaccines are currently at different stages of development, with a few now advancing to the late stage clinical trial. The B
  • Possible but not certain COVID-19 vaccine rolled out this year - Oxford developer
    LONDON, July 21 (Reuters): The University of Oxford's possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty that will happen, the lead developer of the vaccine said on Tuesday. The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of the year. "The end of the year target for getting vac
  • Clinical trials begin for Bharat Biotech's Covid-19 vaccine
    HYDERABAD, JULY 17 (IANS): Hyderabad-based Bharat Biotech on Friday announced that the Phase-I clinical trials of India's first indigenous Covid-19 vaccine Covaxin began across the country on July 15.   "This is a randomised, double-blind, placebo-controlled clinical trial on 375 volunteers in India," the company said in a brief statement.   The leading vaccine maker had announced on June 29 that it successfully developed Covaxin in collaboration wit
  • Russia, despite theft allegations, says deal to make UK-developed COVID-19 vaccine is on
    MOSCOW, July 17 (Reuters): Russia will unveil a deal with AstraZeneca to manufacture a COVID-19 vaccine being developed by the pharmaceuticals giant and Oxford University, its wealth fund head said on Friday, adding this showed Moscow had no need to steal vaccine data.   Britain, Canada and the United States said on Thursday that hackers backed by the Russian state were trying to steal COVID-19 vaccine and treatment research from academic and pharmaceutical institutions
  • Russia trying to steal COVID-19 vaccine data, say UK, U.S. and Canada
    LONDON/OTTAWA, July 16 (Reuters) - Hackers backed by the Russian state are trying to steal COVID-19 vaccine and treatment research from academic and pharmaceutical institutions around the world, Britain’s National Cyber Security Centre (NCSC) said on Thursday.   A co-ordinated statement from Britain, the United States and Canada attributed the attacks to group APT29, also known as ‘Cozy Bear’, which they said was almost certainly operating as part of Russia
  • Oxford COVID-19 vaccine hopes rise with strong trial results
    New Delhi, July 16 (PTI): Researchers at the University of Oxford believe they may have a breakthrough in their search for a COVID-19 vaccine after the team discovered that the jab could provide 'double protection' against the deadly coronavirus following early stage human trials, according to media reports in the United Kingdom.   Blood samples taken from a group of UK volunteers given a dose of the vaccine showed that it stimulated the body to produce both antibodi
  • Swiftly waning COVID-19 immunity poses vaccination challenge
    LONDON, July 14 (Reuters): Emerging evidence that the body's immune defence against COVID-19 may be short-lived makes it even harder for vaccine developers to come up with shots fully able to protect people in future waves of infection, scientists said on Tuesday.   Preliminary studies in China, Germany, Britain and elsewhere have found that patients infected with the novel coronavirus make protective antibodies as part of their immune system's defences, but the
  • 'They needed people' - Brazil volunteers step up to test COVID-19 vaccine
    SAO PAULO, July 14 (Reuters): Luiz Augusto Rizzo, 29, is no specialist in infectious diseases, but he is part of perhaps the most important scientific endeavor in the world today: the hunt for a vaccine against the novel coronavirus.   The pediatric surgeon is one of 2,000 volunteers in Brazil's largest city of Sao Paulo taking part in mass human trials for the experimental coronavirus vaccine developed by researchers at the University of Oxford and AstraZeneca Plc
  • Russia 1st nation to finish human trials for Covid-19 vaccine
    Moscow, July 12 (IANS) Russia has become the first nation to complete clinical trials of Covid-19 vaccine on humans, and the results have proven the medication's effectiveness, the media reported on Sunday.   Chief researcher Elena Smolyarchuk, who heads the Center for Clinical Research on Medications at Sechenov University, told Russian news agency TASS on Sunday that the human trials for the vaccine have been completed at the university and they will be discharged soon
  • Covid vaccine: Assam lab isolates virus
    New Delhi, July 2 (PTI): The Regional Medical Research Centre in Assam's Dibrugarh has become the fourth laboratory in the country to successfully isolate SARS-CoV-2 virus that can be used for the production of a vaccine against COVID-19, state Health Minister Himanta Biswa Sarma said on Wednesday.   Scientists at the RMRC have isolated the COVID-19 virus in VERO-CCL81 cell line in the BSL-3 level lab available at the institute, he told reporters in Guwahati.  
  • BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial
    FRANKFURT, July 1 (Reuters): A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.   The drug is one of 17 being tested on humans in a frantic global race to find a vaccine the world is counting on to end a pandemic that has infected 10.5 million people and killed more than half a million so far.   Th
  • AstraZeneca, Moderna ahead in COVID-19 vaccine race - WHO
    GENEVA, June 26 (Reuters): AstraZeneca's experimental COVID-19 vaccine is probably the world's leading candidate and most advanced in terms of development, the World Health Organization's (WHO) chief scientist said on Friday.   The British drugmaker has already begun large-scale, mid-stage human trials of the vaccine, which was developed by researchers at University of Oxford.   This week, AstraZeneca signed its tenth supply-and-manufacturing deal.
  • WHO-led coalition says $31.3 billion needed for tools to fight COVID-19
    LONDON/GENEVA, June 26 (Reuters): A World Health Organization-led coalition fighting the COVID-19 pandemic is asking government and private sector donors to help raise $31.3 billion in the next 12 months to develop and deliver tests, treatments and vaccines for the disease.   Renewing its call on Friday for global collaboration against the pandemic, it said $3.4 billion had been contributed for the coalition to date, leaving a funding gap of $27.9 billion. Of that, $13.
  • Covid-19 vaccine could come within 1 year: WHO chief
    Brussels, June 26 (IANS) Scientists predict the world may have a Covid-19 vaccine within one year or even a few months earlier, said the Director-General of the World Health Organisation even as he underlined the importance of global cooperation to develop, manufacture and distribute vaccines.   However, making the vaccine available and distributing it to all will be a challenge and requires political will, Tedros Adhanom Ghebreyesus said on Thursday during a meeting with th